These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29873205)

  • 1. Optical spectroscopic sensing of tumor hypoxia.
    Dadgar S; Troncoso JR; Rajaram N
    J Biomed Opt; 2018 Jun; 23(6):1-6. PubMed ID: 29873205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectroscopic investigation of radiation-induced reoxygenation in radiation-resistant tumors.
    Dadgar S; Troncoso JR; Siegel ER; Curry NM; Griffin RJ; Dings RPM; Rajaram N
    Neoplasia; 2021 Jan; 23(1):49-57. PubMed ID: 33220616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines.
    Bussink J; Kaanders JH; Strik AM; Vojnovic B; van Der Kogel AJ
    Radiat Res; 2000 Nov; 154(5):547-55. PubMed ID: 11025651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.
    Wobb J; Krueger SA; Kane JL; Galoforo S; Grills IS; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):820-8. PubMed ID: 26104936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
    Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.
    Hu F; Vishwanath K; Salama JK; Erkanli A; Peterson B; Oleson JR; Lee WT; Brizel DM; Ramanujam N; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):462-469. PubMed ID: 27598811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in tumor hypoxia measured with a double hypoxic marker technique.
    Ljungkvist AS; Bussink J; Rijken PF; Raleigh JA; Denekamp J; Van Der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1529-38. PubMed ID: 11121659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
    Kennedy AS; Raleigh JA; Perez GM; Calkins DP; Thrall DE; Novotny DB; Varia MA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):897-905. PubMed ID: 9128967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers.
    Bussink J; Kaanders JH; van der Kogel AJ
    Radiother Oncol; 2003 Apr; 67(1):3-15. PubMed ID: 12758235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
    Wack LJ; Mönnich D; Yaromina A; Zips D; Baumann M; Thorwarth D
    Med Phys; 2016 Jul; 43(7):4113. PubMed ID: 27370131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
    Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
    Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
    Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
    Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
    Busk M; Jakobsen S; Horsman MR; Mortensen LS; Iversen AB; Overgaard J; Nordsmark M; Ji X; Lee DY; Raleigh JR
    Acta Oncol; 2013 Oct; 52(7):1300-7. PubMed ID: 23962243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of EGFR under tumor hypoxia: identification of a subpopulation of tumor cells responsible for aggressiveness and treatment resistance.
    Hoogsteen IJ; Marres HA; van den Hoogen FJ; Rijken PF; Lok J; Bussink J; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):807-14. PubMed ID: 22420963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Clinical Study to Assess Diffuse Reflectance Spectroscopy with an Auto-Calibrated, Pressure-Sensing Optical Probe in Head and Neck Cancer.
    Rickard AG; Mikati H; Mansourati A; Stevenson D; Krieger M; Rocke D; Esclamado R; Dewhirst MW; Ramanujam N; Lee WT; Palmer GM
    Curr Oncol; 2023 Feb; 30(3):2751-2760. PubMed ID: 36975421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI; Marres HA; Peters JP; Rijken PF; van der Kogel AJ; Kaanders JH
    Oral Oncol; 2008 Apr; 44(4):335-44. PubMed ID: 17689286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Janssen HL; Haustermans KM; Sprong D; Blommestijn G; Hofland I; Hoebers FJ; Blijweert E; Raleigh JA; Semenza GL; Varia MA; Balm AJ; van Velthuysen ML; Delaere P; Sciot R; Begg AC
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1537-49. PubMed ID: 12459383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors.
    Raleigh JA; Chou SC; Arteel GE; Horsman MR
    Radiat Res; 1999 May; 151(5):580-9. PubMed ID: 10319731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
    Mortensen LS; Buus S; Nordsmark M; Bentzen L; Munk OL; Keiding S; Overgaard J
    Acta Oncol; 2010 Oct; 49(7):934-40. PubMed ID: 20831480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
    Hoogsteen IJ; Peeters WJ; Marres HA; Rijken PF; van den Hoogen FJ; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2005 Aug; 76(2):213-8. PubMed ID: 16112214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.